Full-size annual and quarterly year-over-year growth charts for revenue, EPS, operating cash flow, EBITDA, and free cash flow against the 15%, 20%, and 30% bars over 3-, 5-, and 10-year windows, with each metric's valuation multiple vs its own history.
Revenue · 10YDoes not currently clear the 15%+, 20%+, or 30%+ revenue bars over 10Y.
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
| Metric | 10Y CAGR | Median YoY | YoY σ | Qtrs ≥ 20% | Neg. qtrs |
|---|---|---|---|---|---|
| RevenueRevenue | -4.4% | 41.3% | 222.6pp | 31 of 40 | 5 |
| EPSEPS | -12.5% | 44.4% | 889.3pp | 16 of 29 | 12 |
| Op cash flowOperating cash flow | 3.9% | -2% | 1376.8pp | 11 of 35 | 18 |
| EBITDAEBITDA | — | 17.9% | 1004.1pp | 19 of 40 | 13 |
| FCFFree cash flow | — | 11.6% | 147.1pp | 15 of 30 | 15 |
Reported figures over 10Y: annual-series CAGR, median and standard deviation (σ, percentage points) of quarterly year-over-year growth, quarters at or above 20%, and quarters with negative YoY. “—” means the window needs more comparable data.
Scores, qualification bars, and the 0–100 consistency methodology are documented on the compounders list page →
See also: NBIS on the compounders surface · All compounders, ranked